SCHEMBL4906239

SCHEMBL4906239

CCOC(=O)Cc1nc(-c2cccc(-n3cccc3)c2)sc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 1/20 0.46
PKM P14618 1/20 0.46
NFKB1 P19838 1/20 0.46
RAB9A P51151 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RARA P10276 1/20 0.40
RARB P10826 1/20 0.40
RARG P13631 1/20 0.40
LMNA P02545 1/20 0.40
ALOX5 P09917 1/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
RECQL P46063 1/20 0.39
GAA P10253 1/20 0.39
GSK3B P49841 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897981 0.80 DCK (0.38) RARARARBRARGMEN1KMT2A
SCHEMBL4906756 0.78 DCK (0.41) SMN1; SMN2NPC1PKMRAB9AMAPT
SCHEMBL4905523 0.75 MAPT (0.56) TRPM8SMN1; SMN2NPC1PKMNFKB1
SCHEMBL6604649 0.75 TRPM8 (0.56) TRPM8SMN1; SMN2NPC1PKMNFKB1
SCHEMBL4906319 0.73 MAPT (0.49) TRPM8SMN1; SMN2NPC1PKMNFKB1
SCHEMBL4905599 0.73 PTPN11 (0.43) TRPM8SMN1; SMN2NPC1PKMNFKB1
SCHEMBL969119 0.72 MEN1 (0.59) TRPM8SMN1; SMN2NPC1PKMNFKB1
SCHEMBL3534461 0.72 TRPM8 (0.47) TRPM8SMN1; SMN2NPC1PKMNFKB1
SCHEMBL5105903 0.71 GAA (0.64) TRPM8SMN1; SMN2NPC1PKMNFKB1
SCHEMBL4904262 0.69 LMNA (0.45) L3MBTL1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TRPM8 4270/4885SMN1; SMN2 3271/4885NPC1 50/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TRPM8 4317/4885SMN1; SMN2 3404/4885NPC1 59/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TRPM8 4317/4885SMN1; SMN2 3404/4885NPC1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.